TMC8 and cutaneous melanoma: Multivariate analyses based on TMC8 expression (median as the cut-off to divide the patients into high- or low-group) and patient clinical characteristics in the four cohorts showed that TMC8 expression was an independent prognostic biomarker for overall survival in skin melanoma (Figure 4N).